← Product Code [GEX](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX) · K072332

# VARI-LASE WIRE FIBER (K072332)

_Vascular Solutions, Inc. · GEX · Jan 10, 2008 · General, Plastic Surgery · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K072332

## Device Facts

- **Applicant:** Vascular Solutions, Inc.
- **Product Code:** [GEX](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX.md)
- **Decision Date:** Jan 10, 2008
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 878.4810
- **Device Class:** Class 2
- **Review Panel:** General, Plastic Surgery
- **Attributes:** Therapeutic

## Indications for Use

The VARI-LASE WireFiber is indicated for the treatment of varicose veins and varicosities associated with superficial reflux in the Great Saphenous Vein and for treatment of incompetence and reflux of superficial veins in the lower extremity.

## Device Story

The Vari-Lase WireFiber is a 600um core laser fiber (3.5m length) used for endovenous laser treatment of varicose veins. The distal tip features a ceramic and platinum/iridium casing to provide ultrasound visibility, plus a floppy spring tip. Used by physicians in clinical settings, the device delivers laser energy to the vein to treat venous reflux. The platinum/iridium component allows the clinician to visualize the fiber tip via ultrasound during the procedure, facilitating accurate placement and monitoring. The device is intended to improve patient outcomes by addressing venous incompetence.

## Clinical Evidence

Bench testing only. Testing included energy transmission, tip integrity (tensile strength, burn-back, torque response, torsional strength), and biocompatibility. Results confirmed suitability for intended use.

## Technological Characteristics

600um core laser fiber, 3.5m length. Distal tip materials: ceramic and platinum/iridium. Features a distal floppy spring tip. Sterilization method not specified. No software or electronic components.

## Regulatory Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

## Predicate Devices

- Vari-Lase Endovenous Bright™ Tip Fiber ([K070216](/device/K070216.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

K072332

Image /page/0/Picture/1 description: The image is a logo for Vascular Solutions. The logo features a black square with a pixelated top, giving the impression of movement or dissolving. Below the square, the words "Vascular" and "Solutions" are written in a bold, serif font, with "Vascular" in a larger size than "Solutions."

# 510(k) Summary (As required by 21 CFR 807.92(c))

JAN. 10 2008

510(k) Number:_

# Date Prepared

October 1, 2007

## Submitter Information

| Submitter's Name: | Vascular Solutions, Inc.                     |
|-------------------|----------------------------------------------|
| Address:          | 6464 Sycamore Court<br>Minneapolis, MN 55369 |

Contact Person:

Deborah L. Neymark Vice President, Regulatory Affairs Phone 763-656-4349 Fax 763-656-4250

### Device Information

| Trade Name:          | Vari-Lase® WireFiber                                                                                                          |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------|
| Common Name:         | Optical Fiber                                                                                                                 |
| Class:               | II                                                                                                                            |
| Classification Name: | Laser Surgical Instrument for use in General and Plastic<br>Surgery and in Dermatology<br>(21 CFR 870.4810, Product Code GEX) |

#### Predicate Device

Vari-Lase Endovenous Bright™ Tip Fiber (K070216) manufactured by Vascular Solutions, Inc.

# Device Description

The Vari-Lase Wire Fiber is a 600um core laser fiber that is 3.5 meters in length. The distal tip of the fiber is encased in a ceramic and platinum/iridium (provides ultrasound visibility during clinical use) and includes a distal floppy spring tip.

{1}------------------------------------------------

510(k) Summary Varilase Wire Fiber Page 2

### Intended Use/Indications for Use

The VARI-LASE WireFiber is indicated for the treatment of varicose veins and varicosities associated with superficial reflux in the Great Saphenous Vein and for treatment of incompetence and reflux of superficial veins in the lower extremity.

#### Summary of Testing

Bench testing was conducted on the modified laser fiber and included an assessment of physical properties and its ability to achieve its intended use. The results of the tests confirmed the suitability of the device for its intended use. Bench tests included energy transmission, integrity of the tip following simulated clinical use (tensile strength of the ceramic/metal tip, burn-back, torque response and torsional strength) and biocompatibility.

### Statement of Equivalence

The Vari-Lase Wire fiber is substantially equivalent to the currently marketed Vari-Lase Bright Tip Fiber, based on comparisons of the device classification, indications for use, technological characteristics, and sterilization methods.

#### Conclusion

The Vari-Lase Wire Fiber is substantially equivalent to the currently marketed Vari-Lase Fibers, based on comparisons of the device classifications, indications for use, technological characteristics, and sterilization methods. Bench tests confirmed the suitability of the device for its intended use.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized eagle with three tail feathers, representing the department's three main goals: protecting the health of all Americans, providing essential human services, and fostering advances in medicine and public health. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA" are arranged in a circular pattern around the eagle.

Public Health Service

JAN 1 0 2008

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Vascular Solutions, Inc. % Ms. Deborah Neymark VP, Regulatory Affairs, Clinical Research and Reimbursement 6464 Sycamore Court Minnesapolis, Minnesota 55369

Re: K072332

Trade/Device Name: Vari-Lase® Wire Fiber Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: November 30, 2007 Received: December 3, 2007

Dear Ms. Neymark:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set

{3}------------------------------------------------

Page 2 - Ms. Deborah Neymark

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050,

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours.

Mark M Millerson

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use Statement

510(k) Number: K072332

Device Name:

Vari-Lase® Wire Fiber

seat the same of the states

Indications for Use:

The VARI-LASE Wire Fiber is indicated for the treatment of varicose veins and varicosities associated with superficial reflux in the Great Saphenous Vein and for treatment of incompetence and reflux of superficial veins in the lower extremity.

| Prescription Use            | X      | Over-The-Counter Use   |
|-----------------------------|--------|------------------------|
| (Part 21 CFR 801 Subpart D) | AND/OR | (21 CFR 801 Subpart C) |

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, of(Division Sign Off) (ODE)

Division of General, Restorative, and Neurological Devices

510(k) Number 1072332

---

**Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K072332](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K072332)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com